Biologics is fastest growing segment fueling the growth of Inflammatory Bowel Disease Market

Inflammatory Bowel Disease Market 

 


The global Inflammatory Bowel Disease Market is estimated to be valued at US$ 2004.71 Mn or Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Inflammatory Bowel Disease refers to a group of inflammatory conditions of the colon and small intestine. The major types of Inflammatory Bowel Disease are ulcerative colitis and Crohn's disease. Biologics play a crucial role in the treatment of inflammatory bowel disease by targeting specific components of the immune system and help manage symptoms and achieve remission with fewer side effects than other treatment options.


Market key trends:


One of the major trends in the inflammatory bowel disease market is increasing adoption of biologics. Biologics are monoclonal antibodies that target specific components of the immune system involved in inflammatory bowel disease. They include anti-TNF drugs such as infliximab, adalimumab, and golimumab which target tumor necrosis factor-alpha (TNF-α). Biologics provide highly targeted immune modulation and are increasingly becoming first line therapy due to their better efficacy and safety profile over conventional drugs. According to a 2018 report by the Centre for Colitis and Crohn’s disease in Canada, biologics therapy is recommended as the first line treatment for patients with moderate to severe Crohn’s disease or ulcerative colitis to induce and maintain remission.


Segment Analysis 


The global inflammatory bowel disease market Demand is segmented on the basis of disease condition, drug class, and distribution channel. Based on disease condition, the market is segmented into ulcerative colitis and crohn’s disease, with crohn’s disease being the dominating sub segment. Crohn’s disease accounts for over 45% of the market share as it has higher prevalence rate and requires life-long treatment.


Key Takeaways

 


The Global Inflammatory Bowel Disease Market Demand is expected to witness high growth, exhibiting CAGR of 4.9% over the forecast period, due to increasing incidence of inflammatory bowel diseases.

Regional Analysis
North America dominates the global inflammatory bowel disease market with around 40% share due to high per capita healthcare expenditure and established healthcare facilities for diagnosis and treatment of inflammatory bowel diseases. Asia Pacific is the fastest growing region on account of huge patient population base and raising awareness.

Key Players
Key players operating in the inflammatory bowel disease market are Johnson & Johnson Services Inc., AbbVie Inc., Takeda Pharmaceutical Company Ltd., UCB Pharma S.A., Pfizer Inc., Bristol Myers Squibb Co., Roche Holding AG, GlaxoSmithKline Plc, Eli Lilly & Company, and Novartis International AG.

The global inflammatory bowel disease market size for 2023 is US$ 2004.71 Mn. The market is expected to grow at a CAGR of 4.9% during the forecast period of 2023 to 2030.

 

Get more insights, read-  https://www.marketwebjournal.com/inflammatory-bowel-disease-market-growth-and-trnds-analysis-share-size-demand-forecast/ 

Comments

Post a Comment

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Image
   Windsurf Foil Board Market In the exhilarating world of water sports, the Windsurf Foil Board Market emerges as a key player, offering enthusiasts innovative equipment to enhance their riding experience. As this niche market continues to gain traction among windsurfing aficionados worldwide, it undergoes significant shifts influenced by various drivers, challenges, and geographical nuances. The Windsurf Foil Board Market size was valued at  US$ 167.4 Mn in 2024  and is expected to reach  US$ 268.6 Mn by 2031 , growing at a compound annual growth rate  (CAGR) of 7% from 2024 to 2031 Key Takeaways A prominent trend in the Windsurf Foil Board Market Demand is the increasing adoption of foil technology. Foil boards, equipped with hydrofoils beneath the waterline, enable riders to glide effortlessly above the water's surface, providing a thrilling and dynamic experience. This technological innovation has revolutionized the windsurfing landscape, attrac...
Read more

Idiopathic Hypersomnia Treatment Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Idiopathic Hypersomnia

Image
  Idiopathic Hypersomnia Treatment Market Idiopathic hypersomnia is a neurological sleep disorder characterized by excessive daytime sleepiness and long periods of sleep that does not improve even after long sleep. The treatment of idiopathic hypersomnia is done through medication and behavioral therapies. Medications like psychostimulants, serotonin modulators, wakefulness promoting agents are used to treat the condition and increase wakefulness. The increasing prevalence of idiopathic hypersomnia due to genetic and environmental factors is expected to drive the growth of the idiopathic hypersomnia treatment market. The Global Idiopathic Hypersomnia Treatment Market is estimated to be valued at US$ 389.86 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the Idiopathic Hypersomnia Treatment Market are Esaote SPA, Epica Animal Health, IDEXX Laboratories, Carestream Health, IMV Imaging, Fujifilm Hold...
Read more

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Image
  Niemann-Pick Disease Drug Type C Treatment Market Key Takeaways The Niemann-Pick Disease Drug Type C Treatment Market is witnessing significant growth, driven by advancements in medical research and a deeper understanding of the disease pathology. Niemann-Pick Disease Type C (NPC) is a rare genetic disorder characterized by the accumulation of cholesterol and other lipids within cells, leading to progressive neurological and visceral symptoms. With an increasing focus on rare diseases and orphan drug development, the market for NPC treatment is expanding rapidly, offering hope to patients and caregivers. Key players in the pharmaceutical industry are actively investing in research and development to bring novel therapies to market, underscoring the potential for transformative interventions in NPC management. Global Niemann-Pick Disease Drug Type C Treatment Market is estimated to be valued at  US$ 45.40  million  in 2024, and is expected to exhibit a  CAG...
Read more